Cryoprotectants are substances characterised by their ability to reduce cryoinjury of biological materials during the course of freezing. Unfortunately cryoprotectants can be toxic for cells. The aim of this study is to investigate the toxicity of cryoprotectants to early stage ovarian follicles of zebrafish (Danion rerio) before designing protocols for their cryopreservation. Commonly used cryoprotectants methanol, dimethyl sulfoxide (DMSO), propylene glycol (PG) and ethylene glycol (EG) were studied. Experiments were conducted with stage I and II zebrafish ovarian follicles, which were incubated in 50% L-15 medium containing different concentrations of cryoprotectants (0.25-5M) for 30 min at room temperature. Stage III zebrafish ovarian follicles were also used as comparisons. Two different tests were used to assess ovarian follicle viability: trypan blue (TB) and Fluorescein diacetate (FDA) + propidium iodide (PI) staining. Both TB and FDA+PI tests indicated that cryoprotectant toxicity to ovarian follicles increased in the order of methanol, DMSO, PG and EG. FDA+PI test was shown to be more sensitive than TB staining. No Observed Effect Concentrations (NOECs) for stage I and II follicles were 2M, 1M, 0.5M, and 0.25M for methanol, dimethyl sulfoxide (DMSO), propylene glycol (PG) and ethylene glycol (EG) respectively when assessed with FDA+PI. Stage III ovarian follicles appeared to be more sensitive than stage I and II ovarian follicles.
Download full-text PDF |
Source |
---|
JBRA Assist Reprod
January 2025
Racine IVF Unit, Fertility Institute, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Objective: To compare the number and outcomes of elective fertility preservation (FP) before and after the Covid-19 outbreak.
Methods: This retrospective study of 574 women who underwent elective FP between 01/2017-12/2021 included 123 women who underwent the procedure before and 451 who underwent it after the Covid-19 outbreak. The change in the number of women who underwent the procedure each month before and after the pandemic was calculated.
JBRA Assist Reprod
January 2025
Clínica Originare, Medicina Reprodutiva, São Paulo, Brazil.
Endometriosis is a chronic disease that affects around 10% of reproductive age women worldwide and a common cause of infertility. One of its manifestations is ovarian endometriomas, which are present in 17-44% of endometriosis patients. Endometriomas can impair fertility by mechanical stretching and local inflammation, promoting oxidative stress in the surrounding ovarian cortex that could lead to apoptosis and necrosis of early follicles.
View Article and Find Full Text PDFLife Med
February 2024
Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Ovarian aging is mainly characterized by a progressive decline in oocyte quantity and quality, which ultimately leads to female infertility. Various therapies have been established to cope with ovarian aging, among which exosome-based therapy is considered a promising strategy that can benefit ovarian functions via multiple pathways. Here, we isolated and characterized exosomes derived from ovarian follicular fluid and profiled the differential expression patterns of noncoding exosomal RNAs in young and aged women.
View Article and Find Full Text PDFJ Biochem Mol Toxicol
February 2025
Department of Gynecology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Lycopene (LYC) is an extremely powerful antioxidant with the potential to treat a range of diseases and to inhibit ferroptosis. This research aims to elucidate how LYC impacts polycystic ovarian syndrome (PCOS) and the action mechanisms. A PCOS rat model was constructed by injecting DHEA.
View Article and Find Full Text PDFMol Med
January 2025
Reproduction and Genetics Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 42 Wenhua West Road, Lixia District, Jinan, 250014, Shandong, China.
Background: Polycystic ovary syndrome (PCOS) is a common gynecological disease accompanied by multiple clinical features, including anovulation, hyperandrogenism, and polycystic ovarian morphology, leading to infertility. Formononetin (FMN), which is a major bioactive isoflavone compound in Astragalus membranaceus, exerts anti-inflammatory effects. However, whether FMN is effective in the treatment of PCOS remains unknown.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!